SEC Form 4 · accession 0000899243-19-006922
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Valentine
Officer — See Remarks
Period of report
Mar 7, 2019
Accepted (ET)
Mar 8, 2019 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.76 | Mar 7, 2019 | A | 29,900 | A | — | Mar 6, 2029 | Common Stock | 29,900 | 29,900 | D |
Explanation of responses
- F1This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service.
Remarks
Chief Legal Officer and General Counsel